Similarly to our observations in the group of MPS II patients treated with ERT, we did not observe a positive effect of recombinant human alpha-L-iduronidase (laronidase) on the growth of patients with MPS I [14]. This evidence concerns the gene IDUA and mucopolysaccharidosis type 2.